Biomarker Study for Cancer

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Audubon Bioscience

Disqualifiers: Under 18, Prisoner, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

10000 Participants Needed

Trial Summary

What is the purpose of this trial?

Study purpose: to explore the entire spectrum of proteomic and genomic changes (amongst others) involved in diseases and in healthy/control populations. The Study is designed to discover biomarkers, develop and validate diagnostic assays, instruments and therapeutics as well as other medical research. Specifically, researchers may analyze proteins, RNA, DNA copy number changes, including large and small (1,000-100,000 kb) scale rearrangements, transcription profiles, epigenetic modifications, sequence variation, and sequence in both diseased tissue and case-matched germline DNA from Subjects.

Eligibility Criteria

This study is for individuals aged 20-39 or 70-79 who identify as Caucasian/Non-Hispanic and are citizens of the US or Canada. Participants should generally be in good health, without any specific medical conditions mentioned.

Inclusion Criteria

Are you between the ages of 80-89?

In general, would you consider yourself to be in good health?

Are you a citizen of the United States or Canada?

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Specimen Collection

Collection of high-quality tissue, whole teeth, and biofluid specimens from consented subjects

Ongoing throughout study

Analysis

Testing specimens and associated clinical data to confirm pathology diagnosis and assess RNA and DNA integrity

Ongoing throughout study

Follow-up

Participants are monitored for safety and effectiveness after specimen collection and analysis

4 weeks

Treatment Details

Trial Overview The trial is an observational study with no interventions. It aims to discover biomarkers by analyzing a wide range of biological materials like proteins and DNA from both healthy people and those with various diseases.

Participant Groups

Group I: Subjects with various conditions Experimental Treatment 1 Intervention

Subjects that have been diagnosed with a condition of interest such as Diabetes, NASH, Breast Cancer, Endometriosis, or other designated condition.

Group II: Healthy Experimental Treatment 1 Intervention

Healthy subjects with no history of chronic disease

Who Is Running the Clinical Trial?

Audubon Bioscience

Lead Sponsor

Trials

1

Recruited

10,000+